164 related articles for article (PubMed ID: 22447203)
1. Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors.
Valach J; Fík Z; Strnad H; Chovanec M; Plzák J; Cada Z; Szabo P; Sáchová J; Hroudová M; Urbanová M; Steffl M; Pačes J; Mazánek J; Vlček C; Betka J; Kaltner H; André S; Gabius HJ; Kodet R; Smetana K; Gál P; Kolář M
Int J Cancer; 2012 Dec; 131(11):2499-508. PubMed ID: 22447203
[TBL] [Abstract][Full Text] [Related]
2. Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression.
Wu MH; Hong HC; Hong TM; Chiang WF; Jin YT; Chen YL
Clin Cancer Res; 2011 Mar; 17(6):1306-16. PubMed ID: 21385934
[TBL] [Abstract][Full Text] [Related]
3. A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts.
Jensen DH; Therkildsen MH; Dabelsteen E
J Oral Pathol Med; 2015 Oct; 44(9):714-21. PubMed ID: 25420473
[TBL] [Abstract][Full Text] [Related]
4. Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas.
Saussez S; Decaestecker C; Cludts S; Ernoux P; Chevalier D; Smetana K; André S; Leroy X; Gabius HJ
Anticancer Res; 2009 Jan; 29(1):59-65. PubMed ID: 19331133
[TBL] [Abstract][Full Text] [Related]
5. Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas.
Fík Z; Valach J; Chovanec M; Mazánek J; Kodet R; Kodet O; Tachezy R; Foltynová E; André S; Kaltner H; Gabius HJ; Smetana K
J Oral Pathol Med; 2013 Feb; 42(2):166-73. PubMed ID: 22650413
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 upregulation during tumor progression in head and neck cancer.
Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
[TBL] [Abstract][Full Text] [Related]
8. CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling.
Horn LC; Schreiter C; Canzler A; Leonhardt K; Einenkel J; Hentschel B
Ann Diagn Pathol; 2013 Dec; 17(6):531-5. PubMed ID: 24183311
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of myofibroblast cell lines from oral squamous cell carcinoma.
Sobral LM; Zecchin KG; Nascimento de Aquino S; Lopes MA; Graner E; Coletta RD
Oncol Rep; 2011 Apr; 25(4):1013-20. PubMed ID: 21271223
[TBL] [Abstract][Full Text] [Related]
10. Myofibroblast stromal presence and distribution in squamous epithelial carcinomas, oral dysplasia and hyperkeratosis.
Seifi S; Shafaei S; Shafigh E; Sahabi SM; Ghasemi H
Asian Pac J Cancer Prev; 2010; 11(2):359-64. PubMed ID: 20843116
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
Plzák J; Betka J; Smetana K; Chovanec M; Kaltner H; André S; Kodet R; Gabius HJ
Eur J Cancer; 2004 Oct; 40(15):2324-30. PubMed ID: 15454259
[TBL] [Abstract][Full Text] [Related]
12. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
[TBL] [Abstract][Full Text] [Related]
14. Synthetic polyamine BPA-C8 inhibits TGF-β1-mediated conversion of human dermal fibroblast to myofibroblasts and establishment of galectin-1-rich extracellular matrix in vitro.
Mifková A; Kodet O; Szabo P; Kučera J; Dvořánková B; André S; Koripelly G; Gabius HJ; Lehn JM; Smetana K
Chembiochem; 2014 Jul; 15(10):1465-70. PubMed ID: 24867251
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1: a link between tumor hypoxia and tumor immune privilege.
Le QT; Shi G; Cao H; Nelson DW; Wang Y; Chen EY; Zhao S; Kong C; Richardson D; O'Byrne KJ; Giaccia AJ; Koong AC
J Clin Oncol; 2005 Dec; 23(35):8932-41. PubMed ID: 16219933
[TBL] [Abstract][Full Text] [Related]
17. Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.
Kim HJ; Do IG; Jeon HK; Cho YJ; Park YA; Choi JJ; Sung CO; Lee YY; Choi CH; Kim TJ; Kim BG; Lee JW; Bae DS
Hum Pathol; 2013 Jan; 44(1):62-8. PubMed ID: 22939954
[TBL] [Abstract][Full Text] [Related]
18. NF-Kappa-B downregulation strategies in head and neck cancer treatment.
Patel A; Miller L; Ahmed K; Ondrey F
Otolaryngol Head Neck Surg; 2004 Sep; 131(3):288-95. PubMed ID: 15365549
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
Betka J; Plzák J; Smetana K; Gabius HJ
Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
[TBL] [Abstract][Full Text] [Related]
20. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx.
Barth PJ; Schenck zu Schweinsberg T; Ramaswamy A; Moll R
Virchows Arch; 2004 Mar; 444(3):231-4. PubMed ID: 14758552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
